U.S. medical device maker Stryker on Thursday maintained its full-year profit outlook but missed Wall Street estimates for ...
Zimmer Biomet saw a strong first quarter, and U.S. growth in particular was bolstered by the hip franchise, CEO Ivan Tornos said in an earnings call. “Our U.S. hip franchise grew 5% in the quarter as ...
Osteoarthritis has no cure, but researchers have developed new therapies that help aging or damaged joints repair themselves ...
The next generation of Zimmer Biomet’s Rosa Shoulder robot is in the works, CEO Ivan Tornos said in a first quarter earnings call. Zimmer Biomet’s Rosa Shoulder earned FDA approval and debuted in 2024 ...
Zimmer Biomet Holdings Inc. lost its bid Friday to end fraud litigation over its acquisition of a soft tissue repair platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results